Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease

European Journal of Neurology

Volumn 19, Issue 2, 2012, Pages 199-206

  Pan, P L ^a   Song, W ^a   Shang, H F ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gray matter; Idiopathic Parkinson's disease; Magnetic resonance imaging; Meta analysis; Signed differential mapping; Voxel based morphometry

Indexed keywords

BRAIN MAPPING; BRAIN SIZE; GRAY MATTER; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PARKINSON DISEASE; INFERIOR FRONTAL GYRUS; INSULA; NEUROIMAGING; ORBITAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SUPERIOR TEMPORAL GYRUS; SYSTEMATIC REVIEW; VOXEL BASED MORPHOMETRY;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, UNMYELINATED; NEUROIMAGING; PARKINSON DISEASE;

EID: 84856062359     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03474.x     Document Type: Review

References (65)

1. Mechelli A, Price C, Friston K, et al. Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 2005; 1: 105-113.
2. Ashburner J, Friston K. Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
3. Ashburner J, Friston K. Why voxel-based morphometry should be used. Neuroimage 2001; 14: 1238-1243.
4. Giuliani N, Calhoun V, Pearlson G, et al. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia. Schizophr Res 2005; 74: 135-148.
5. Costafreda S, David A, Brammer M. A parametric approach to voxel-based meta-analysis. Neuroimage 2009; 46: 115-122.
6. Radua J, Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 2009; 195: 393.
7. Chen Z, Ma L. Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: a voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler 2010; 11: 549-554.
8. Bora E, Fornito A, Yücel M, et al. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 2010; 67: 1097-1105.
9. Obeso J, Rodriguez-Oroz M, Rodriguez M, et al. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 2000; 23: S8-S19.
10. Poewe W. Non motor symptoms in Parkinson's disease. Eur J Neurol 2008; 15: 14-20.
11. Baev K, Greene K, Marciano F, et al. Physiology and pathophysiology of cortico-basal ganglia-thalamocortical loops: theoretical and practical aspects. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 771-804.
12. Parent A, Hazrati L. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 1995; 20: 91-127.
13. Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel based morphometry study. Mov Disord 2008; 23: 42-46.
14. Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005; 64: 224.
15. Dalaker T, Zivadinov R, Larsen J, et al. Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord 2010; 25: 629-633.
16. Cordato N, Duggins A, Halliday G, et al. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005; 128: 1259.
17. Tir M, Delmaire C, le Thuc V, et al. Motor-related circuit dysfunction in MSA-P: usefulness of combined whole-brain imaging analysis. Mov Disord 2009; 24: 863-870.
18. Stroup D, Berlin J, Morton S, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008.
19. Bax L, Yu L, Ikeda N, et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006; 6: 50.
20. Martin W, Wieler M, Gee M, et al. Temporal lobe changes in early, untreated Parkinson's disease. Mov Disord 2009; 24: 1949-1954.
21. Nishio Y, Hirayama K, Takeda A, et al. Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010; 17: 1090-1097.
22. Jubault T, Brambati S, Degroot C, et al. Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS ONE 2009; 4: e8247.
23. Kostic V, Agosta F, Petrovic I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010; 75: 857.
24. Meppelink A, de Jong B, Teune L, et al. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations. Mov Disord 2010; 26: 142-147.
25. Ramirez-Ruiz B, Martí M, Tolosa E, et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007; 14: 750-756.
26. Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia. Mov Disord 2009; 24: 1740-1746.
27. Burton E, McKeith I, Burn D, et al. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791.
28. Beyer M, Janvin C, Larsen J, et al. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007; 78: 254.
29. Pereira J, Junqué C, Martí M, et al. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009; 24: 1193-1199.
30. Camicioli R, Gee M, Bouchard T, et al. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism. Parkinsonism Relat Disord 2009; 15: 187.
31. Karagulle Kendi A, Lehericy S, Luciana M, et al. Altered diffusion in the frontal lobe in Parkinson disease. Am J Neuroradiol 2008; 29: 501.
32. Ramnani N, Owen A. Anterior prefrontal cortex: insights into function from anatomy and neuroimaging. Nat Rev Neurosci 2004; 5: 184-194.
33. Rolls E. The functions of the orbitofrontal cortex. Brain Cogn 2004; 55: 11-29.
34. Braak H, Braak E, Yilmazer D, et al. Nigral and extranigral pathology in Parkinson's disease. J Neural Transm Suppl 1995; 46: 15.
35. Jellinger K. Pathology of Parkinson's disease. Mol Chem Neuropathol 1991; 14: 153-197.
36. Owen A. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004; 10: 525.
37. Lewis S, Dove A, Robbins T, et al. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003; 23: 6351.
38. Ibarretxe Bilbao N, Junque C, Tolosa E, et al. Neuroanatomical correlates of impaired decision making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009; 30: 1162-1171.
39. Gleichgerrcht E, Ibáñez A, Roca M, et al. Decision-making cognition in neurodegenerative diseases. Nat Rev Neurol 2010; 6: 611-623.
40. Frank M, Claus E. Anatomy of a decision: Striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol Rev 2006; 113: 300.
41. Dove A, Pollmann S, Schubert T, et al. Prefrontal cortex activation in task switching: an event-related fMRI study. Cogn Brain Res 2000; 9: 103-109.
42. Chaudhuri K, Schapira A. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464-474.
43. Brooks D, Doder M. Depression in Parkinson's disease. Curr Opin Neurol 2001; 14: 465.
44. Westermann B, Wattendorf E, Schwerdtfeger U, et al. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2008; 79: 19.
45. Lotze M, Reimold M, Heymans U, et al. Reduced ventrolateral fmri response during observation of emotional gestures related to the degree of dopaminergic impairment in parkinson disease. J Cogn Neurosci 2009; 21: 1321-1331.
46. Le Jeune F, Péron J, Biseul I, et al. Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain 2008; 131: 1599.
47. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for CFT binding with positron emission tomography. Ann Neurol 1999; 45: 601-610.
48. Masaoka Y, Yoshimura N, Inoue M, et al. Impairment of odor recognition in Parkinson's disease caused by weak activations of the orbitofrontal cortex. Neurosci Lett 2007; 412: 45-50.
49. Ceballos-Baumann AO. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. J Neurol 2003; 250(Suppl 1): I15-I23.
50. Wu T, Long X, Zang Y, et al. Regional homogeneity changes in patients with Parkinson's disease. Hum Brain Mapp 2009; 30: 1502-1510.
51. Bodden M, Dodel R, Kalbe E. Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review. Mov Disord 2010; 25: 13-27.
52. Adolphs R. Cognitive neuroscience of human social behaviour. Nat Rev Neurosci 2003; 4: 165-178.
53. Frith C, Frith U. Interacting minds - a biological basis. Science 1999; 286: 1692.
54. Pell M, Leonard C. Facial expression decoding in early Parkinson's disease. Cogn Brain Res 2005; 23: 327-340.
55. Pell M, Leonard C. Processing emotional tone from speech in Parkinson's disease: a role for the basal ganglia. Cogn Affect Behav Neurosci 2003; 3: 275.
56. Péron J, Vicente S, Leray E, et al. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease. Neuropsychologia 2009; 47: 406-414.
57. Saltzman J, Strauss E, Hunter M, et al. Theory of mind and executive functions in normal human aging and Parkinson's disease. J Int Neuropsychol Soc 2000; 6: 781-788.
58. Poletti M, Enrici I, Bonuccelli U, et al. Theory of mind in Parkinson's disease. Behav Brain Res 2011; 219: 342-350.
59. Augustine J. The insular lobe in primates including humans. Neurol Res 1985; 7: 2.
60. Augustine J. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Rev 1996; 22: 229-244.
61. Papapetropoulos S, Mash D. Insular pathology in Parkinson's disease patients with orthostatic hypotension. Parkinsonism Relat Disord 2007; 13: 308-311.
62. Kikuchi A, Takeda A, Kimpara T, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001; 193: 29-36.
63. Schneider E. Autonomic disturbances in Parkinson's disease and their treatment. Der Nervenarzt 1999; 70: S26.
64. Leopold N, Kagel M. Laryngeal deglutition movement in Parkinson's disease. Neurology 1997; 48: 373.
65. Clark L, Bechara A, Damasio H, et al. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 2008; 131: 1311.